Cited by 681Advanced Drug Delivery SystemsDrug Solubulity and Delivery SystemsProteins in Food Systems

The DOI matches its Crossref record; 217 of the 219 references it cites were found in a registry or an index.

Approaches for enhancing oral bioavailability of peptides and proteins

Open access

Renukuntla, Jwala, Vadlapudi, Aswani Dutt, Patel, Ashaben, Boddu, Sai H.S., Mitra, Ashim K.·2013·International Journal of Pharmaceutics

DOI 10.1016/j.ijpharm.2013.02.030PMC PMC3680128

Open this paper in CoChat — free account

Abstract

Oral delivery of peptide and protein drugs faces immense challenge partially due to the gastrointestinal (GI) environment. In spite of considerable efforts by industrial and academic laboratories, no major breakthrough in the effective oral delivery of polypeptides and proteins has been accomplished. Upon oral administration, gastrointestinal epithelium acts as a physical and biochemical barrier for absorption of proteins resulting in low bioavailability (typically less than 1-2%). An ideal oral drug delivery system should be capable of (a) maintaining the integrity of protein molecules until it reaches the site of absorption, (b) releasing the drug at the target absorption site, where the delivery system appends to that site by virtue of specific interaction, and (c) retaining inside the gastrointestinal tract irrespective of its transitory constraints. Various technologies have been explored to overcome the problems associated with the oral delivery of macromolecules such as insulin, gonadotropin-releasing hormones, calcitonin, human growth factor, vaccines, enkephalins, and interferons, all of which met with limited success. This review article intends to summarize the physiological barriers to oral delivery of peptides and proteins and novel pharmaceutical approaches to circumvent these barriers and enhance oral bioavailability of these macromolecules.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.ijpharm.2013.02.030

Cites

217 of 217 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

RETRACTED: In situ-forming hydrogels for sustained ophthalmic drug delivery
Nanjawade, B. K., Manvi, F. V., & Manjappa, A. S. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.07.009 · Cited by 213
Retracted
Physiology of the Gastrointestinal Tract
Johnson, L. R. (2006) · Elsevier eBooks · doi:10.1016/b978-0-12-088394-3.x5000-4 · Cited by 4,616
Hydrogels in pharmaceutical formulations
Peppas, N. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00090-4 · Cited by 4,011
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. D. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,417
Nanoparticle-based targeted drug delivery
Singh, R., & Lillard, J. W. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.12.004 · Cited by 2,845
In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse
Schwarze, S. R., Ho, A. L., Vocero-Akbani, A. M., & Dowdy, S. F. (1999) · Science · doi:10.1126/science.285.5433.1569 · Cited by 2,418
Pharmaceutical Applications of Cyclodextrins. 1. Drug Solubilization and Stabilization
Loftsson, Þ., & Brewster, M. E. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950534b · Cited by 2,179
Cyclodextrins as pharmaceutical solubilizers
Brewster, M. E., & Loftsson, Þ. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.012 · Cited by 1,942
Penetration enhancers
Williams, A. C., & Barry, B. W. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.025 · Cited by 1,746
Prodrugs: design and clinical applications
Rautio, J., Kumpulainen, H., Heimbach, T., Oliyai, R., Oh, D.-M., Järvinen, T., & Savolainen, J. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2468 · Cited by 1,681

Show all 219 references

Research works printed but not linked: 3

Gangurde, 2011, Approaches for peptides and proteins by colon specific delivery: Review, Int. J. Pharm. Frontier Res., 1, 110
Vinay Kumar, 2011, Colon targeting drug delivery system: A review on recent approaches, Int. J. Pharm. Biomed. Sci., 2, 11
Yang, H.P.A. (CA), Nguyen, Vu Anh (San Jose, CA), Dong, Liang C. (Mountain View, CA), Wong, Patrick S. L. (Palo Alto, CA), 1999. Peptide Formulation, in: States, U. (Ed.). Alza Corporation (Palo Alto, CA).

Sorted by citations

Basics and Recent Advances in Peptide and Protein Drug Delivery
Bruno, B. J., Miller, G. D., & Lim, C. S. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.104 · Cited by 771
Biocompatibility, biodegradation and biomedical applications of poly(lactic acid)/poly(lactic-co-glycolic acid) micro and nanoparticles
Elmowafy, E. M., Tiboni, M., & Soliman, M. E. (2019) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-019-00439-x · Cited by 642
Physicochemical properties of mucus and their impact on transmucosal drug delivery
Leal, J., Smyth, H. D. C., & Ghosh, D. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.09.018 · Cited by 560
Thin films as an emerging platform for drug delivery
Karki, S., Kim, H., Na, S.-J., Shin, D., Jo, K., & Lee, J. (2016) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2016.05.004 · Cited by 544
Nanoparticles for oral delivery: Design, evaluation and state-of-the-art
Date, A. A., Hanes, J. S., & Ensign, L. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.016 · Cited by 551
Encapsulation, protection, and delivery of bioactive proteins and peptides using nanoparticle and microparticle systems: A review
McClements, D. J. (2018) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2018.02.002 · Cited by 469
Orally Absorbed Cyclic Peptides
Nielsen, D. S., Shepherd, N. E., Xu, W., Lucke, A. J., Stoermer, M. J., & Fairlie, D. P. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00838 · Cited by 454
Current state and challenges in developing oral vaccines
Ramirez, J. E. V., Sharpe, L. A., & Peppas, N. A. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.04.008 · Cited by 425
Advances in Oral Drug Delivery Systems: Challenges and Opportunities
Lou, J., Duan, H., Qin, Q., Teng, Z., Gan, F., Zhou, X., & Zhou, X. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020484 · Cited by 403
Peptides with Dual Antimicrobial and Anticancer Activities
Felício, M. R., Silva, O. N., Gonçalves, S., Santos, N. C., & Franco, O. L. (2017) · Frontiers in Chemistry · doi:10.3389/fchem.2017.00005 · Cited by 393
Bioavailability of bioactive peptides derived from food proteins across the intestinal epithelial membrane: A review
Xu, Q., Hong, H., Wu, J., & Yan, X. (2019) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2019.02.050 · Cited by 372
Enzymatic hydrolysis and microbial fermentation: The most favorable biotechnological methods for the release of bioactive peptides
Cruz‐Casas, D. E., Aguilar, C. N., Ascacio‐Valdés, J. A., Rodríguez-Herrera, R., Chávez‐González, M. L., & Flores‐Gallegos, A. C. (2021) · Food Chemistry Molecular Sciences · doi:10.1016/j.fochms.2021.100047 · Cited by 434
Oral delivery of proteins and peptides: Challenges, status quo and future perspectives
Zhu, Q., Chen, Z., Paul, P. K., Lü, Y., Wu, W., & Qi, J. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.04.001 · Cited by 366
A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives
Muheem, A., Shakeel, F., Jahangir, M. A., Anwar, M., Mallick, N., Jain, G. K., Warsi, M. H., & Ahmad, F. J. (2014) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2014.06.004 · Cited by 343
Advances in nanoparticle and microparticle delivery systems for increasing the dispersibility, stability, and bioactivity of phytochemicals
McClements, D. J. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.08.004 · Cited by 322
Nanoparticles: Oral Delivery for Protein and Peptide Drugs
Cao, S., Xu, S., Wang, H., Ling, Y., Dong, J., Xia, R.-D., & Sun, X. (2019) · AAPS PharmSciTech · doi:10.1208/s12249-019-1325-z · Cited by 307
Current Evidence on the Bioavailability of Food Bioactive Peptides
Amigo, L., & Hernández-Ledesma, B. (2020) · Molecules · doi:10.3390/molecules25194479 · Cited by 311
Tutorial on monoclonal antibody pharmacokinetics and its considerations in early development
Ovacik, M., & Lin, K. (2018) · Clinical and Translational Science · doi:10.1111/cts.12567 · Cited by 299
Discovery and Mechanism of Highly Efficient Cyclic Cell-Penetrating Peptides
Qian, Z., Martyna, A., Hard, R. L., Wang, J., Appiah‐Kubi, G., Coss, C. C., Phelps, M. A., Rossman, J. S., & Pei, D. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00226 · Cited by 301
Glycosylation, an effective synthetic strategy to improve the bioavailability of therapeutic peptides
Moradi, S. V., Hussein, W. M., Varamini, P., Simerská, P., & Tóth, I. (2016) · Chemical Science · doi:10.1039/c5sc04392a · Cited by 289
Are intact peptides absorbed from the healthy gut in the adult human?
Miner-Williams, W. M., Stevens, B. R., & Moughan, P. J. (2014) · Nutrition Research Reviews · doi:10.1017/s0954422414000225 · Cited by 290
Injectable Microfluidic Hydrogel Microspheres for Cell and Drug Delivery
Zhao, Z., Wang, Z., Li, G., Cai, Z., Wu, J., Wang, L., Deng, L., Cai, M., & Cui, W. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202103339 · Cited by 282
A review of natural polysaccharides for drug delivery applications: Special focus on cellulose, starch and glycogen
Gopinath, V., Sekaran, S., Al‐Maleki, A. R., Ramesh, M., & Vadivelu, J. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.136 · Cited by 281
Micro and nanoscale technologies in oral drug delivery
Ahadian, S., Finbloom, J. A., Mofidfar, M., Diltemiz, S. E., Nasrollahi, F., Davoodi, E., Hosseini, V., Mylonaki, I., Sangabathuni, S., Montazerian, H., et al. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.012 · Cited by 280
Microparticles, microcapsules and microspheres: A review of recent developments and prospects for oral delivery of insulin
Wong, C. Y. J., Al‐Salami, H., & Dass, C. R. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.12.036 · Cited by 275
Designing biopolymer microgels to encapsulate, protect and deliver bioactive components: Physicochemical aspects
McClements, D. J. (2016) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2016.12.005 · Cited by 271
Lipid-based nanocarriers for oral peptide delivery
Niu, Z., Conejos‐Sánchez, I., Griffin, B. T., O’Driscoll, C. M., & Alonso, M. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.001 · Cited by 266
Pharmapolymers in the 21st century: Synthetic polymers in drug delivery applications
Englert, C., Brendel, J. C., Majdanski, T. C., Yildirim, T., Schubert, S., Gottschaldt, M., Windhab, N., & Schubert, U. S. (2018) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2018.07.005 · Cited by 254
Scalable fabrication of size-controlled chitosan nanoparticles for oral delivery of insulin
He, Z., Santos, J. L., Tian, H., Huang, H., Hu, Y., Liu, L., Leong, K. W., Chen, Y., & Mao, H. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.03.028 · Cited by 245
Advances in nutraceutical delivery systems: From formulation design for bioavailability enhancement to efficacy and safety evaluation
Gonçalves, R. F. S., Martins, J. T., Duarte, C. M. M., Vicente, A. A., & Pinheiro, A. C. (2018) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2018.06.011 · Cited by 243
Robust scalable high throughput production of monodisperse drops
Amstad, E., Chemama, M., Eggersdorfer, M. L., Arriaga, L. R., Brenner, M. P., & Weitz, D. A. (2016) · Lab on a Chip · doi:10.1039/c6lc01075j · Cited by 227
Ocular delivery of proteins and peptides: Challenges and novel formulation approaches
Mandal, A., Pal, D., Agrahari, V., Trinh, H. M., Joseph, M. A., & Mitra, A. K. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.01.008 · Cited by 232
Self-citation
Application of chitosan/alginate nanoparticle in oral drug delivery systems: prospects and challenges
Li, S., Zhang, H., Chen, K., Jin, M., Vu, S. H., Jung, S., He, N., Zhou, Z. G., & Lee, M. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2058646 · Cited by 221
Recent Advances in Protein and Peptide Drug Delivery: A Special Emphasis on Polymeric Nanoparticles
Patel, A., Patel, M., Yang, X., & Mitra, A. K. (2014) · Protein and Peptide Letters · doi:10.2174/0929866521666140807114240 · Cited by 209
Self-citation
The Influence of Nanoparticle Properties on Oral Bioavailability of Drugs
Wang, Y., Pi, C., Feng, X., Hou, Y., Zhao, L., & Wei, Y. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s257269 · Cited by 217
Influence of peptide characteristics on their stability, intestinal transport, and in vitro bioavailability: A review
Wang, B., Xie, N., & Li, B. (2018) · Journal of Food Biochemistry · doi:10.1111/jfbc.12571 · Cited by 206
Bioactive peptides in plant-derived foodstuffs
Maestri, E., Marmiroli, M., & Marmiroli, N. (2016) · Journal of Proteomics · doi:10.1016/j.jprot.2016.03.048 · Cited by 197
Cyclic peptide natural products chart the frontier of oral bioavailability in the pursuit of undruggable targets
Naylor, M. R., Bockus, A. T., Blanco, M.-J., & Lokey, R. S. (2017) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2017.04.012 · Cited by 190
Advanced progress of microencapsulation technologies: In vivo and in vitro models for studying oral and transdermal drug deliveries
Lam, P.-L., & Gambari, R. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.12.028 · Cited by 185
Oral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities
Wong, C. Y. J., Martinez, J., & Dass, C. R. (2016) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12607 · Cited by 188
Recent Advancements in Non-Invasive Formulations for Protein Drug Delivery
Bajracharya, R., Song, J. G., Back, S. Y., & Han, H. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.09.004 · Cited by 183
Digestion and bioavailability of bioactive phytochemicals
Karaś, M., Jakubczyk, A., Szymanowska, U., Złotek, U., & Zielińska, E. (2016) · International Journal of Food Science & Technology · doi:10.1111/ijfs.13323 · Cited by 186
An overview of in vitro, ex vivo and in vivo models for studying the transport of drugs across intestinal barriers
Xu, Y., Shrestha, N., Véronique Préat, A., & Beloqui, A. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.005 · Cited by 192
An Updated Overview of the Emerging Role of Patch and Film-Based Buccal Delivery Systems
Jacob, S., Nair, A. B., Boddu, S. H. S., Gorain, B., Sreeharsha, N., & Shah, J. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081206 · Cited by 199
Self-citation
Considering food matrix and gastrointestinal effects in enhancing bioactive peptide absorption and bioavailability
Sun, X., Acquah, C., Aluko, R. E., & Udenigwe, C. C. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103680 · Cited by 178
A Fragment-Based Method to Discover Irreversible Covalent Inhibitors of Cysteine Proteases
Kathman, S. G., Xu, Z., & Statsyuk, A. V. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500345q · Cited by 172
Novel and revisited approaches in nanoparticle systems for buccal drug delivery
Macedo, A. S., Castro, P. M., Roque, L., Thomé, N. G., Reis, C. P., Pintado, M., & Fonte, P. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.006 · Cited by 173
Peptide-functionalized liposomes as therapeutic and diagnostic tools for cancer treatment
Sonju, J. J., Dahal, A., Singh, S. S., & Jois, S. D. S. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.055 · Cited by 175
Laponite‐Based Nanomaterials for Drug Delivery
Kiaee, G., Dimitrakakis, N., Sharifzadeh, S., Kim, H., Avery, R. K., Mollazadeh‐Moghaddam, K., Haghniaz, R., Yalcintas, E. P., de Barros, N. R., Karamikamkar, S., et al. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202102054 · Cited by 170
Multifunctional oral delivery systems for enhanced bioavailability of therapeutic peptides/proteins
Han, Y., Gao, Z., Chen, L., Kang, L., Huang, W., Jin, M., Wang, Q., & Bae, Y. H. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.01.004 · Cited by 165
Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome
Lee, Y., Kamada, N., & Moon, J. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114021 · Cited by 169
Orally Active Peptides: Is There a Magic Bullet?
Räder, A. F. B., Weinmüller, M., Reichart, F., Schumacher‐Klinger, A., Merzbach, S., Gilon, C., Hoffman, A., & Kessler, H. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201807298 · Cited by 163
Recently isolated antidiabetic hydrolysates and peptides from multiple food sources: a review
Kehinde, B. A., & Sharma, P. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1528206 · Cited by 166
Docking small peptides remains a great challenge: an assessment using AutoDock Vina
Rentzsch, R., & Renard, B. Y. (2015) · Briefings in Bioinformatics · doi:10.1093/bib/bbv008 · Cited by 164
Targeting of gastrointestinal tract for amended delivery of protein/peptide therapeutics: Strategies and industrial perspectives
Pawar, V. K., Meher, J. G., Singh, Y., Chaurasia, M., Reddy, B. S., & Chourasia, M. K. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.09.031 · Cited by 154
Basic and recent advances in marine antihypertensive peptides: Production, structure-activity relationship and bioavailability
Abdelhedi, O., & Nasri, M. (2019) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2019.04.002 · Cited by 153
Recent developments in natural and synthetic polymeric drug delivery systems used for the treatment of osteoarthritis
Rahimi, M., Charmi, G., Matyjaszewski, K. A., Banquy, X., & Pietrasik, J. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.01.003 · Cited by 160
In vivo proof of concept of oral insulin delivery based on a co-administration strategy with the cell-penetrating peptide penetratin
Nielsen, E. J. B., Yoshida, S., Kamei, N., Iwamae, R., Khafagy, E., Olsen, J., Rahbek, U. L., Pedersen, B. L., Takayama, K., & Takeda‐Morishita, M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.022 · Cited by 151
A comprehensive review of bioactive peptides obtained from animal byproducts and their applications
Bechaux, J., Gatellier, P., Page, J. L., Drillet, Y., & Santé-Lhoutellier, V. (2019) · Food & Function · doi:10.1039/c9fo01546a · Cited by 153
Recent Advances in Encapsulation, Protection, and Oral Delivery of Bioactive Proteins and Peptides using Colloidal Systems
Perry, S. L., & McClements, D. J. (2020) · Molecules · doi:10.3390/molecules25051161 · Cited by 148
Overcoming the Shortcomings of Peptide-Based Therapeutics
Lamers, C. (2022) · Future Drug Discovery · doi:10.4155/fdd-2022-0005 · Cited by 154
Targeted oral delivery of BmpB vaccine using porous PLGA microparticles coated with M cell homing peptide-coupled chitosan
Jiang, T., Singh, B., Li, H.-S., Kim, Y.-K., Kang, S., Nah, J., Choi, Y., & Cho, C. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.073 · Cited by 143
Challenges in delivering therapeutic peptides and proteins: A silk-based solution
Wu, J., Sahoo, J. K., Li, Y., Xu, Q., & Kaplan, D. L. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.02.011 · Cited by 149
Polysaccharides constructed hydrogels as vehicles for proteins and peptides. A review
Drăgan, E. S., & Dinu, M. V. (2019) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2019.115210 · Cited by 136
Efficacy, safety and cardiovascular outcomes of once‐daily oral semaglutide in patients with type 2 diabetes: The PIONEER programme
Thethi, T. K., Pratley, R., & Meier, J. J. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14054 · Cited by 134
A new era for oral peptides: SNAC and the development of oral semaglutide for the treatment of type 2 diabetes
Aroda, V. R., Blonde, L., & Pratley, R. E. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09735-8 · Cited by 135
Barriers and Strategies for Oral Peptide and Protein Therapeutics Delivery: Update on Clinical Advances
Baral, K. C., & Choi, K. Y. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17040397 · Cited by 149
Nanocarrier Fabrication and Macromolecule Drug delivery: Challenges and Opportunities
Agrahari, V., Agrahari, V., & Mitra, A. K. (2016) · Therapeutic Delivery · doi:10.4155/tde-2015-0012 · Cited by 137
Self-citation
pH-responsive and enzymatically-responsive hydrogel microparticles for the oral delivery of therapeutic proteins: Effects of protein size, crosslinking density, and hydrogel degradation on protein delivery
Koetting, M. C., Guido, J. F., Gupta, M., Zhang, A., & Peppas, N. A. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.11.023 · Cited by 123
Oral delivery strategies for nutraceuticals: Delivery vehicles and absorption enhancers
Gleeson, J. P., Ryan, S. M., & Brayden, D. J. (2016) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2016.05.007 · Cited by 128
Fish skin gelatin hydrolysates as dipeptidyl peptidase IV inhibitors and glucagon-like peptide-1 stimulators improve glycaemic control in diabetic rats: A comparison between warm- and cold-water fish
Wang, T.-Y., Hsieh, C., Hung, C.-C., Jao, C., Chen, M., & Hsu, K. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.09.037 · Cited by 118
Biocompatible and Mucoadhesive Bacterial Cellulose-g-Poly(acrylic acid) Hydrogels for Oral Protein Delivery
Ahmad, N., Amin, M. C. I. M., Mahali, S. M., Ismail, I., & Chuang, V. T. G. (2014) · Molecular Pharmaceutics · doi:10.1021/mp5003015 · Cited by 118
Effects of pharmaceutical PEGylation on drug metabolism and its clinical concerns
Zhang, X., Wang, H., Ma, Z., & Wu, B. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.967679 · Cited by 117
Enzyme-Assisted Discovery of Antioxidant Peptides from Edible Marine Invertebrates: A Review
Chai, T., Law, Y.-C., Wong, F., & Kim, S. (2017) · Marine Drugs · doi:10.3390/md15020042 · Cited by 117
Novel strategies in the oral delivery of antidiabetic peptide drugs – Insulin, GLP 1 and its analogs
Ismail, R., & Csóka, I. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.03.015 · Cited by 116
Protein based therapeutic delivery agents: Contemporary developments and challenges
Yin, L., Yuvienco, C., & Montclare, J. K. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.04.036 · Cited by 112
An updated review on food‐derived bioactive peptides: Focus on the regulatory requirements, safety, and bioavailability
Patil, P. J., Usman, M. A., Zhang, C., Mehmood, A., Zhou, M., Teng, C., & Li, X. (2022) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12911 · Cited by 117
Benzothiazoles as potential antiviral agents
Asiri, Y. I., Alsayari, A., Muhsinah, A. B., Mabkhot, Y. N., & Hassan, M. Z. (2020) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13331 · Cited by 109
β-Lactoglobulin: An efficient nanocarrier for advanced delivery systems
Shafaei, Z., Ghalandari, B., Vaseghi, A., Divsalar, A., Haertlé, T., Saboury, A. A., & Sawyer, L. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.03.007 · Cited by 106
Plant‐Based Hollow Microcapsules for Oral Delivery Applications: Toward Optimized Loading and Controlled Release
Potroz, M. G., Mundargi, R. C., Gillissen, J. J. J., Tan, E., Meker, S., Park, J. H., Jung, H., Park, S.-H., Cho, D., Bang, S. I., et al. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201700270 · Cited by 106
Throughput enhancement of parallel step emulsifier devices by shear-free and efficient nozzle clearance
Stolovicki, E., Ziblat, R., & Weitz, D. A. (2017) · Lab on a Chip · doi:10.1039/c7lc01037k · Cited by 106
Peptides as drug delivery vehicles across biological barriers
Ghosh, D., Peng, X., Leal, J., & Mohanty, R. P. (2018) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-017-0374-0 · Cited by 102
Stimuli-responsive graphene-incorporated multifunctional chitosan for drug delivery applications: a review
Gooneh-Farahani, S., Naimi‐Jamal, M. R., & Naghib, S. M. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1556257 · Cited by 103
Chitosan Nanoparticles as Oral Drug Carriers
Guadarrama-Escobar, O. R., Serrano-Castañeda, P., Anguíano-Almazán, E., Vázquez‐Durán, A., Peña‐Juárez, M. C., Vera‐Graziano, R., Morales-Florido, M. I., Pérez, B. R., Rodríguez-Cruz, I. M., Miranda-Calderón, J. E., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054289 · Cited by 115
Peptide Lipidation – A Synthetic Strategy to Afford Peptide Based Therapeutics
Kowalczyk, R., Harris, P. W. R., Williams, G. M., Yang, S., & Brimble, M. A. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-66095-0_9 · Cited by 103
Bioactive Carbohydrates and Peptides in Foods: An Overview of Sources, Downstream Processing Steps and Associated Bioactivities
Hayes, M., & Tiwari, B. K. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160922485 · Cited by 101
Clinical Pharmacology and Interplay of Immune Checkpoint Agents: A Yin-Yang Balance
Géraud, A., Gougis, P., Vozy, A., Anquetil, C., Allenbach, Y., Romano, E., Funck‐Brentano, E., Moslehi, J. J., Johnson, D. B., & Salem, J. (2020) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-022820-093805 · Cited by 97
Characterization of the binding of MRTX1133 as an avenue for the discovery of potential KRASG12D inhibitors for cancer therapy
Issahaku, A. R., Mukelabai, N., Agoni, C., Rudrapal, M., Aldosari, S. M., Almalki, S. G., & Khan, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-22668-1 · Cited by 93
Oral Delivery of Protein Drugs Bioencapsulated in Plant Cells
Kwon, K., & Daniell, H. (2016) · Molecular Therapy · doi:10.1038/mt.2016.115 · Cited by 99
Fluorophore labeling of a cell-penetrating peptide induces differential effects on its cellular distribution and affects cell viability
Birch, D., Christensen, M. V., Stærk, D., Franzyk, H., & Nielsen, H. M. (2017) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2017.09.015 · Cited by 100
Versatile spider venom peptides and their medical and agricultural applications
Saez, N. J., & Herzig, V. (2018) · Toxicon · doi:10.1016/j.toxicon.2018.11.298 · Cited by 95
Pectin based multi-particulate carriers for colon-specific delivery of therapeutic agents
Das, S. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120814 · Cited by 94
The Current and Promising Oral Delivery Methods for Protein- and Peptide-Based Drugs
Nicze, M., Borówka, M., Dec, A., Niemiec, A., Bułdak, Ł., & Okopień, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020815 · Cited by 100
Visible‐Light‐Promoted Stereoselective C(sp 3 )−H Glycosylation for the Synthesis of C ‐Glycoamino Acids and C ‐Glycopeptides
Qi, R., Wang, C., Ma, Z., Wang, H., Chen, Q., Liu, L., Pan, D., Ren, X., Wang, R., & Xu, Z. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202200822 · Cited by 93
Oral peptide delivery: challenges and the way ahead
Dubey, S. K., Parab, S., Dabholkar, N., Agrawal, M., Singhvi, G., Alexander, A., Bapat, R. A., & Kesharwani, P. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.01.001 · Cited by 94
Self-emulsifying drug delivery systems in oral (poly)peptide drug delivery
Leonavičiǖtė, G., & Bernkop‐Schnürch, A. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1068287 · Cited by 90
Millet derived bioactive peptides: A review on their functional properties and health benefits
Majid, A., & G., P. P. C. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2019.1686342 · Cited by 89
Soluble eggshell membrane protein-loaded chitosan/fucoidan nanoparticles for treatment of defective intestinal epithelial cells
Lee, M.-C., & Huang, Y. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.03.113 · Cited by 88
Nano and microscale delivery platforms for enhanced oral peptide/protein bioavailability
Tong, T., Wang, L., You, X., & Wu, J. (2020) · Biomaterials Science · doi:10.1039/d0bm01151g · Cited by 89
Design, characterisation, and bioefficiency of insulin–chitosan nanoparticles after stabilisation by freeze-drying or cross-linking
Diop, M., Auberval, N., Viciglio, A., Langlois, A., Bietiger, W., Mura, C., Péronet, C., Bekel, A., Julien-David, D., Zhao, M., et al. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.05.065 · Cited by 88

Authors: Renukuntla, J., Vadlapudi, A. D., Patel, A., Boddu, S. H. S., & Mitra, A. K.
Affiliations: South College (US)
University of Missouri–Kansas City (US)
University of Toledo (US)
Corresponding author: Mitra, Ashim K.
ORCID: Vadlapudi, Aswani Dutt
Boddu, Sai H.S.
Venue: International Journal of Pharmaceutics
Publisher: Elsevier BV
Published: 2013-04
Volume: 447
Issue: 1-2
Pages: 75-93
ISSN: 0378-5173 (ISSN-L)
DOI: 10.1016/j.ijpharm.2013.02.030
PMC: PMC3680128
OpenAlex: W2008173042
Cited by: 681
References: 219
Citations by year: 2026: 37 · 2025: 55 · 2024: 47 · 2023: 55 · 2022: 67 · 2021: 40 · 2020: 67 · 2019: 55 · 2018: 61 · 2017: 63 · 2016: 49 · 2015: 37 · 2014: 34 · 2013: 11
FWCI: 5.50
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: International Journal of Pharmaceutics (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: NIH (R01 GM064320-03, R01EY09171, R01EY010659, R01 AI071199-01A2)
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
Life Sciences › Agricultural and Biological Sciences › Food Science › Proteins in Food Systems
Keywords: oral bioavailability, gastrointestinal barrier, protein stability, drug absorption, peptide delivery, insulin, gonadotropin-releasing hormone, vaccines, interferon, enkephalin, growth factors
MeSH terms: Administration, Oral, Animals, Biological Availability, Chemistry, Pharmaceutical, Humans, Intestinal Absorption, Peptides, Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Approaches for enhancing oral bioavailability of peptides and proteins

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks